UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 880

Sortiert nach

Interstitial cystitis, bladder pain syndrome, hypersensitive bladder, and interstitial cystitis/bladder pain syndrome – clarification of definitions and relationships

International journal of urology, 2019-06, Vol.26 (S1), p.20-24

Homma, Yukio

2019

Volltextzugriff (PDF)

Hypersensitive bladder: A solution to confused terminology and ignorance concerning interstitial cystitis

International journal of urology, 2014-04, Vol.21 (S1), p.43-47

Homma, Yukio

2014

Volltextzugriff (PDF)

Interstitial cystitis/bladder pain syndrome: The evolving landscape, animal models and future perspectives

International journal of urology, 2020-06, Vol.27 (6), p.491-503

2020

Volltextzugriff (PDF)

The International Continence Society (ICS) report on the terminology for adult male lower urinary tract and pelvic floor symptoms and dysfunction

Neurourology and urodynamics, 2019-02, Vol.38 (2), p.433-477

2019

Volltextzugriff (PDF)

Clinical guidelines for interstitial cystitis/bladder pain syndrome

International journal of urology, 2020-07, Vol.27 (7), p.578-589

2020

Volltextzugriff (PDF)

Integrated molecular analysis of clear-cell renal cell carcinoma

Nature genetics, 2013-08, Vol.45 (8), p.860

2013

Volltextzugriff (PDF)

Current status of clinical trials assessing oncolytic virus therapy for urological cancers

International journal of urology, 2017-05, Vol.24 (5), p.342-351

2017

Volltextzugriff (PDF)

A novel prognostic factor TRIM44 promotes cell proliferation and migration, and inhibits apoptosis in testicular germ cell tumor

Cancer science, 2017-01, Vol.108 (1), p.32-41

2017

Volltextzugriff (PDF)

Hypersensitive bladder: Towards clear taxonomy surrounding interstitial cystitis

International journal of urology, 2013-08, Vol.20 (8), p.742-743

Homma, Yukio

2013

Volltextzugriff (PDF)

Hunner-Type (Classic) Interstitial Cystitis: A Distinct Inflammatory Disorder Characterized by Pancystitis, with Frequent Expansion of Clonal B-Cells and Epithelial Denudation

PloS one, 2015-11, Vol.10 (11), p.e0143316-e0143316

2015

Volltextzugriff (PDF)

Silodosin, a new α1A‐adrenoceptor‐selective antagonist for treating benign prostatic hyperplasia: results of a phase III randomized, placebo‐controlled, double‐blind study in Japanese men

BJU international, 2006-11, Vol.98 (5), p.1019-1024

2006

Volltextzugriff (PDF)

Clinical guidelines for male lower urinary tract symptoms and benign prostatic hyperplasia

International journal of urology, 2017-10, Vol.24 (10), p.716-729

2017

Volltextzugriff (PDF)

Clinical guidelines for interstitial cystitis and hypersensitive bladder updated in 2015

International journal of urology, 2016-07, Vol.23 (7), p.542-549

2016

Volltextzugriff (PDF)

An empirical Bayesian framework for somatic mutation detection from cancer genome sequencing data

Nucleic acids research, 2013-04, Vol.41 (7), p.e89

2013

Volltextzugriff (PDF)

A randomized, double-blind, placebo- and propiverine-controlled trial of the novel antimuscarinic agent imidafenacin in Japanese patients with overactive bladder

International journal of urology, 2009-05, Vol.16 (5), p.499-506

2009

Volltextzugriff (PDF)

Molecular Taxonomy of Interstitial Cystitis/Bladder Pain Syndrome Based on Whole Transcriptome Profiling by Next-Generation RNA Sequencing of Bladder Mucosal Biopsies

The Journal of urology, 2019-08, Vol.202 (2), p.101097JU0000000000000234-300

2019

Volltextzugriff (PDF)

Symptom assessment tool for overactive bladder syndrome—overactive bladder symptom score

Urology (Ridgewood, N.J.), 2006-08, Vol.68 (2), p.318-323

2006

Volltextzugriff (PDF)

Recurrent somatic mutations underlie corticotropin-independent Cushing's syndrome

Science (American Association for the Advancement of Science), 2014-05, Vol.344 (6186), p.917-920

2014

Volltextzugriff (PDF)

Relationship between the frequency of electrocautery of Hunner lesions and changes in bladder capacity in patients with Hunner type interstitial cystitis

Scientific reports, 2021-01, Vol.11 (1), p.105-6, Article 105

2021

Volltextzugriff (PDF)

RQ-00434739, a novel TRPM8 antagonist, inhibits prostaglandin E2-induced hyperactivity of the primary bladder afferent nerves in rats

Life sciences (1973), 2019-02, Vol.218, p.89-95

2019

Volltextzugriff (PDF)

Clinical guidelines for interstitial cystitis and hypersensitive bladder syndrome

International journal of urology, 2009-07, Vol.16 (7), p.597-615

2009

Volltextzugriff (PDF)

Psychometric Validation of the English Version of the Overactive Bladder Symptom Score

Urology (Ridgewood, N.J.), 2014-07, Vol.84 (1), p.46-50

2014

Volltextzugriff (PDF)

Turkish validation of the overactive bladder symptom score (OABSS) and evaluation of mirabegron treatment response

International Urogynecology Journal, 2019-12, Vol.30 (12), p.2121-2126

2019

Volltextzugriff (PDF)

Increased mRNA Expression of Genes Involved in Pronociceptive Inflammatory Reactions in Bladder Tissue of Interstitial Cystitis

The Journal of urology, 2013-11, Vol.190 (5), p.1925-1931

2013

Volltextzugriff (PDF)

Lower urinary tract symptomatology: Its definition and confusion

International journal of urology, 2008-01, Vol.15 (1), p.35-43

Homma, Yukio

2008

Volltextzugriff (PDF)

1 – 25 von 880

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(692)
Mit Volltextzugriff
(746)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Interstitial cystitis, bladder pain syndrome, hypersensitive bladder, and interstitial cystitis/bladder pain syndrome – clarification of definitions and relationships

Hypersensitive bladder: A solution to confused terminology and ignorance concerning interstitial cystitis

Interstitial cystitis/bladder pain syndrome: The evolving landscape, animal models and future perspectives

The International Continence Society (ICS) report on the terminology for adult male lower urinary tract and pelvic floor symptoms and dysfunction

Clinical guidelines for interstitial cystitis/bladder pain syndrome

Integrated molecular analysis of clear-cell renal cell carcinoma

Current status of clinical trials assessing oncolytic virus therapy for urological cancers

A novel prognostic factor TRIM44 promotes cell proliferation and migration, and inhibits apoptosis in testicular germ cell tumor

Hypersensitive bladder: Towards clear taxonomy surrounding interstitial cystitis

Hunner-Type (Classic) Interstitial Cystitis: A Distinct Inflammatory Disorder Characterized by Pancystitis, with Frequent Expansion of Clonal B-Cells and Epithelial Denudation

Silodosin, a new α1A‐adrenoceptor‐selective antagonist for treating benign prostatic hyperplasia: results of a phase III randomized, placebo‐controlled, double‐blind study in Japanese men

Clinical guidelines for male lower urinary tract symptoms and benign prostatic hyperplasia

Clinical guidelines for interstitial cystitis and hypersensitive bladder updated in 2015

An empirical Bayesian framework for somatic mutation detection from cancer genome sequencing data

A randomized, double-blind, placebo- and propiverine-controlled trial of the novel antimuscarinic agent imidafenacin in Japanese patients with overactive bladder

Molecular Taxonomy of Interstitial Cystitis/Bladder Pain Syndrome Based on Whole Transcriptome Profiling by Next-Generation RNA Sequencing of Bladder Mucosal Biopsies

Symptom assessment tool for overactive bladder syndrome—overactive bladder symptom score

Recurrent somatic mutations underlie corticotropin-independent Cushing's syndrome

Relationship between the frequency of electrocautery of Hunner lesions and changes in bladder capacity in patients with Hunner type interstitial cystitis

RQ-00434739, a novel TRPM8 antagonist, inhibits prostaglandin E2-induced hyperactivity of the primary bladder afferent nerves in rats

Clinical guidelines for interstitial cystitis and hypersensitive bladder syndrome

Psychometric Validation of the English Version of the Overactive Bladder Symptom Score

Turkish validation of the overactive bladder symptom score (OABSS) and evaluation of mirabegron treatment response

Increased mRNA Expression of Genes Involved in Pronociceptive Inflammatory Reactions in Bladder Tissue of Interstitial Cystitis

Lower urinary tract symptomatology: Its definition and confusion

Suchergebnisse filtern